Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
807K
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
134K
-
Shares change
-
+115K
-
Total reported value, excl. options
-
$277K
-
Value change
-
+$236K
-
Number of buys
-
5
-
Number of sells
-
-1
-
Price
-
$2.06
Significant Holders of GRI Bio, Inc. - Common stock, par value $0.0001 per share (GRI) as of Q3 2025
8 filings reported holding GRI - GRI Bio, Inc. - Common stock, par value $0.0001 per share as of Q3 2025.
GRI Bio, Inc. - Common stock, par value $0.0001 per share (GRI) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 134K shares
of 807K outstanding shares and own 16.66% of the company stock.
Largest 8 shareholders include DRW Securities, LLC (101K shares), VANGUARD GROUP INC (17K shares), GEODE CAPITAL MANAGEMENT, LLC (12.4K shares), Tower Research Capital LLC (TRC) (4.02K shares), BlackRock, Inc. (211 shares), SBI Securities Co., Ltd. (117 shares), UBS Group AG (27 shares), and BANK OF AMERICA CORP /DE/ (22 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.